Literature DB >> 5013262

A rapid protein test for acoustic neurinoma.

H Silverstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5013262     DOI: 10.1001/archotol.1972.00770080344003

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


× No keyword cloud information.
  7 in total

1.  Dysfunction of the cochlea contributing to hearing loss in acoustic neuromas: an underappreciated entity.

Authors:  Christof Roosli; Fred H Linthicum; Sebahattin Cureoglu; Saumil N Merchant
Journal:  Otol Neurotol       Date:  2012-04       Impact factor: 2.311

2.  Proteome of human perilymph.

Authors:  Andrew C Lysaght; Shyan-Yuan Kao; Joao A Paulo; Saumil N Merchant; Hanno Steen; Konstantina M Stankovic
Journal:  J Proteome Res       Date:  2011-08-03       Impact factor: 4.466

3.  Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells.

Authors:  Vitor Y R Soares; Nadia A Atai; Takeshi Fujita; Sonam Dilwali; Sarada Sivaraman; Lukas D Landegger; Fred H Hochberg; Carlos A P C Oliveira; Fayez Bahmad; Xandra O Breakefield; Konstantina M Stankovic
Journal:  Neuro Oncol       Date:  2016-05-18       Impact factor: 12.300

4.  A dual wedge microneedle for sampling of perilymph solution via round window membrane.

Authors:  Hirobumi Watanabe; Luis Cardoso; Anil K Lalwani; Jeffrey W Kysar
Journal:  Biomed Microdevices       Date:  2016-04       Impact factor: 2.838

5.  The Role of Tumor Necrosis Factor Alpha (TNFα)in Hearing Loss and Vestibular Schwannomas.

Authors:  Yin Ren; Konstantina M Stankovic
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-02-17

6.  Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage.

Authors:  Sonam Dilwali; Lukas D Landegger; Vitor Y R Soares; Daniel G Deschler; Konstantina M Stankovic
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

7.  Proteome of normal human perilymph and perilymph from people with disabling vertigo.

Authors:  Hsiao-Chun Lin; Yin Ren; Andrew C Lysaght; Shyan-Yuan Kao; Konstantina M Stankovic
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.